When patients in Europe walk into a pharmacy and discover that their regular medication is unavailable, their initial reaction is usually distress. However, the European Medicines Agency (EMA) wants them to know they are not alone. Across the continent, chemists, doctors, regulators, and patient organisations are collaborating to make important drugs accessible. 

The EMA's new awareness campaign, #ItTakesATeam, emphasises a coordinated, system-wide effort to address one of the EU's most critical public health challenges: pharmaceutical shortages. 

Medicine shortages have become a growing worry throughout Europe, affecting everything from antibiotics to pain relievers. These shortages are the result of a complicated, worldwide supply chain that involves manufacturing, transportation, and distribution networks. When any link in this system fails, pharmaceutical availability can be disrupted in several nations. 

This means that shortages are more than just a logistical concern; they are also a question of public health infrastructure. The EMA acknowledges that long-term solutions must go beyond emergency fixes, necessitating more collaboration, improved communication, and mutual trust among all healthcare stakeholders. 

The #ItTakesATeam campaign represents this transformation. Rather than a top-down strategy, the EMA encourages shared responsibility among regulators, chemists, doctors, and patients. "When patients can't get a medicine in a pharmacy, their distress is understandable, but they are never alone," said Jorge Batista of the Pharmaceutical Group of the European Union (PGEU). "There's a whole team working to find solutions." 

The campaign was developed in collaboration with numerous professional and consumer organisations, including the European Consumer Organisation, the European Association of Hospital Pharmacists, the European Association of Nuclear Medicine, and the European Paediatric Neurology Society, among others. 

Emer Cooke, the EMA's Executive Director, describes this collaboration as "a step forward in how we engage with healthcare professionals and patients." For the first time, these organisations have collaborated on a communication campaign, signalling a new era of shared ownership and partnership in public health. 

The campaign's fundamental pillar is transparency. The EMA thinks that open communication reduces public fear and fosters trust, which are critical in times of health crises. To increase public engagement, a webinar on November 4th will invite patients, healthcare professionals, and consumers to learn more about the EU's regulatory process and how they may effectively manage shortages. 

Behind the awareness initiatives is practical action. According to recent data, EU chemists spent an average of 10.6 hours per week handling shortages in 2024. The majority of instances (76%) involved antibiotics, followed by pain relievers (43%) and anaesthetics (37%). 

To retain access, generic substitution is still the most popular method, adopted by 89% of chemists. Other options include compounding formulations (64%) and sourcing from different vendors (61%). 

These numbers demonstrate that, despite the hurdles, the system is changing and evolving to ensure patient care. 

Medicine shortages continue to be a major challenge for European healthcare systems, but the EMA's collaborative model demonstrates that improvement is attainable when everyone works together. The #ItTakesATeam project promotes transparency, teamwork, and innovation, providing a positive vision for a more resilient and patient-centered Europe.